These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22586641)

  • 1. Placing bets on biotech.
    Weintraub K
    Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641
    [No Abstract]   [Full Text] [Related]  

  • 2. Investing in oncology biotech stocks.
    Feuerstein A
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):879-80. PubMed ID: 18185485
    [No Abstract]   [Full Text] [Related]  

  • 3. The era of cancer discovery.
    Cantley LC; Baselga J
    Cancer Discov; 2011 Jun; 1(1):1. PubMed ID: 22586302
    [No Abstract]   [Full Text] [Related]  

  • 4. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 5. BIO 2006 Annual International Convention. The expanding biotech industry of France.
    Zarkowska T
    IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302
    [No Abstract]   [Full Text] [Related]  

  • 6. Cetuximab in colon cancer.
    Holmer AF
    N Engl J Med; 2004 Oct; 351(15):1575-6; author reply 1575-6. PubMed ID: 15470223
    [No Abstract]   [Full Text] [Related]  

  • 7. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 8. Era of personalized medicine may herald end of soaring cancer costs.
    Keogh B
    J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
    [No Abstract]   [Full Text] [Related]  

  • 9. What's fueling the biotech engine-2007.
    Aggarwal S
    Nat Biotechnol; 2008 Nov; 26(11):1227-33. PubMed ID: 18997759
    [No Abstract]   [Full Text] [Related]  

  • 10. Roche chases stake in medical sequencing.
    Hayden EC
    Nature; 2012 Apr; 484(7393):152. PubMed ID: 22498604
    [No Abstract]   [Full Text] [Related]  

  • 11. On the biotech pharm, a race to harvest new cancer cures.
    Roush W
    Science; 1997 Nov; 278(5340):1039-40. PubMed ID: 9381202
    [No Abstract]   [Full Text] [Related]  

  • 12. A venture capital view of challenges, opportunities, and innovation in biomedical research.
    Ratcliffe LT
    Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaining medical momentum.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):19-23. PubMed ID: 15175707
    [No Abstract]   [Full Text] [Related]  

  • 14. Deal-making trends in oncology.
    Moore K; Walker J
    Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466
    [No Abstract]   [Full Text] [Related]  

  • 15. Business barriers slowing the pace of cancer immunotherapy research and development.
    Tuma RS
    J Natl Cancer Inst; 2007 Nov; 99(21):1570-3. PubMed ID: 17971521
    [No Abstract]   [Full Text] [Related]  

  • 16. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotechnology: delivering on the promise.
    Greenwood JC
    Sci Transl Med; 2010 Jan; 2(13):13cm1. PubMed ID: 20371460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Financial toxicity' looms as cancer combinations proliferate.
    Morrison C
    Nat Biotechnol; 2015 Aug; 33(8):783-4. PubMed ID: 26252117
    [No Abstract]   [Full Text] [Related]  

  • 20. Little biotech on the prairie.
    Wolfson W
    Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.